RT Journal Article
SR Electronic
T1 Cooperative virus propagation in COVID-19 transmission
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.05.20092361
DO 10.1101/2020.05.05.20092361
A1 Ziwei Dai
A1 Jason W. Locasale
YR 2020
UL http://medrxiv.org/content/early/2020/09/18/2020.05.05.20092361.abstract
AB The global pandemic due to the emergence of a novel coronavirus (COVID-19) is a threat to humanity. There remains an urgent need to understand its transmission characteristics and design effective interventions to mitigate its spread. In this study, we define a non-linear (known in biochemistry models as allosteric or cooperative) relationship between viral shedding, viral dose and COVID-19 infection propagation. We develop a mathematical model of the dynamics of COVID-19 to link quantitative features of viral shedding, human exposure and transmission in nine countries impacted by the ongoing COVID-19 pandemic, and state-wide transmission in the United States of America (USA). The model was then used to evaluate the efficacy of interventions against virus transmission. We found that cooperativity was important to capture country-specific transmission dynamics and leads to resistance to mitigating transmission in mild or moderate interventions. The behaviors of the model emphasize that strict interventions greatly limiting both virus shedding and human exposure are indispensable to achieving effective containment of COVID-19. Finally, in the USA we find that by the summer of 2021, a difference of about 1.5 million deaths may be observed depending on whether the interventions are to be maintained strictly or lifted in entirety.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJWL thanks the Marc Lustgarten Foundation, the National Institutes of Health (R01CA193256) and the American Cancer Society (129832-RSG-16-214-01-TBE) for their generous support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable for this studyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code used in this study are available at the GitHub page of the Locasale Lab. Complete results of fitting and predicting COVID-19 transmission dynamics in states of the USA are available at: https://drziweidai.com/COVID-19.html. https://github.com/LocasaleLab/COVID_19_models https://drziweidai.com/COVID-19.html